Amrutanjan Health Care has informed that a meeting of the Board of Directors is scheduled to be held on November 09, 2017, to consider and approve the Un-audited Financial Results along with the Limited Review Report for the quarter and half year ended September 30, 2017; and Declaration of 1st interim dividend for the financial year 2017-18. In view of the above, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct to regulate, monitor and report trading by insiders, the trading window for dealing in the securities of the Company shall remain closed for the Specified Persons (Directors & Designated Employees) from November 02, 2017 to November 12, 2017.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |